Leilani R Townsend, DO | |
5225 Cirque Dr W Ste 200, University Place, WA 98467-3639 | |
(253) 848-3000 | |
(253) 845-8750 |
Full Name | Leilani R Townsend |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 15 Years |
Location | 5225 Cirque Dr W Ste 200, University Place, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215265079 | NPI | - | NPPES |
2030105 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | OP60387586 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Idaho Dermatology Pa | 2365404431 | 14 |
News Archive
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive.
Scientists at Wake Forest University School of Medicine and colleagues have developed new research mice to help them better understand how the body makes and uses "good" cholesterol to protect against heart attacks and strokes.
It has taken scientists at the University of Miami's Diabetes Research Institute eight long years of painstaking research, but they believe they have finally pinned down Insulin, the hormone most closely linked to diabetes, to be the cause of the inherited form of the blood sugar disease.
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
› Verified 2 days ago
Entity Name | North Idaho Dermatology Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215936638 PECOS PAC ID: 2365404431 Enrollment ID: O20041101000539 |
News Archive
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive.
Scientists at Wake Forest University School of Medicine and colleagues have developed new research mice to help them better understand how the body makes and uses "good" cholesterol to protect against heart attacks and strokes.
It has taken scientists at the University of Miami's Diabetes Research Institute eight long years of painstaking research, but they believe they have finally pinned down Insulin, the hormone most closely linked to diabetes, to be the cause of the inherited form of the blood sugar disease.
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Leilani R Townsend, DO 1703 S Meridian Ste 101, Puyallup, WA 98371-7590 Ph: (253) 848-3000 | Leilani R Townsend, DO 5225 Cirque Dr W Ste 200, University Place, WA 98467-3639 Ph: (253) 848-3000 |
News Archive
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, led by Guy's and St Thomas' clinicians, over 90% survive.
Scientists at Wake Forest University School of Medicine and colleagues have developed new research mice to help them better understand how the body makes and uses "good" cholesterol to protect against heart attacks and strokes.
It has taken scientists at the University of Miami's Diabetes Research Institute eight long years of painstaking research, but they believe they have finally pinned down Insulin, the hormone most closely linked to diabetes, to be the cause of the inherited form of the blood sugar disease.
BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.
› Verified 2 days ago
Dr. Thomas Hirota, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5225 Cirque Dr W, University Place, WA 98467 Phone: 253-848-3000 | |
Dr. Jennifer Paek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5225 Cirque Dr W Ste 200, University Place, WA 98467 Phone: 253-564-3365 | |
Dr. Kimberly Anne Wenner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5225 Cirque Dr W Ste 200, University Place, WA 98467 Phone: 253-848-3000 Fax: 253-845-8750 | |
Maureen A Mooney, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5225 Cirque Dr W Ste 200, University Place, WA 98467 Phone: 253-848-3000 Fax: 253-845-8750 | |
Robert F Findlay, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5225 Cirque Dr W Ste 200, University Place, WA 98467 Phone: 253-848-3000 Fax: 253-840-6514 |